Verastem (VSTM) Change in Cash (2011 - 2026)
Verastem's (VSTM) quarterly Change in Cash came in at -$39.4 million in Q1 2026, down 237.17% year-on-year from $28.8 million in Q1 2025, and down 158.62% quarter-over-quarter from $67.3 million in Q4 2025.
Verastem (VSTM) Change in Cash (2011 - 2026) Analysis & Trends
Verastem's Change in Cash history runs 16 years deep, the most recent figure standing at -$39.4 million for Q1 2026.
- On a quarterly basis, Change in Cash fell 237.17% year-over-year to -$39.4 million in Q1 2026; TTM through Mar 2026 was $48.0 million, a 36.25% increase from a year earlier, with the FY2025 full-year figure at $116.2 million, up 1063.7% from the prior year.
- Change in Cash declined to -$39.4 million in Q1 2026 per VSTM's latest filing, from $67.3 million in the prior quarter.
- Across five years, Change in Cash topped out at $85.6 million in Q2 2023 and bottomed at -$87.6 million in Q3 2023.
- The 5-year median for Change in Cash is $15.2 million (2022), against an average of $8.5 million.
- Across the five-year window, Change in Cash tumbled 676.46% in 2023 and jumped 4492.63% in 2025, its largest moves.
- Year by year, Change in Cash stood at -$3.6 million in 2022, then tumbled by 392.65% to -$17.7 million in 2023, then tumbled by 37.68% to -$24.4 million in 2024, then surged by 376.24% to $67.3 million in 2025, then tumbled by 158.62% to -$39.4 million in 2026.
- Per Business Quant, the three latest VSTM Change in Cash figures stand at -$39.4 million (Q1 2026), $67.3 million (Q4 2025), and -$26.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | -39.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.44 Mn |
| Dec 31, 2025 | 67.28 Mn |
| Sep 30, 2025 | -26.62 Mn |
| Jun 30, 2025 | 46.75 Mn |
| Mar 31, 2025 | 28.75 Mn |
| Dec 31, 2024 | -24.36 Mn |
| Sep 30, 2024 | 29.80 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 3.52 Mn |
| Dec 31, 2023 | -17.69 Mn |
| Sep 30, 2023 | -87.56 Mn |
| Jun 30, 2023 | 85.58 Mn |
| Mar 31, 2023 | 22.96 Mn |
| Dec 31, 2022 | -3.59 Mn |
| Sep 30, 2022 | 15.19 Mn |
| Jun 30, 2022 | 17.26 Mn |
| Mar 31, 2022 | 25.44 Mn |
| Dec 31, 2021 | -3.06 Mn |
| Sep 30, 2021 | -658,000.00 |
| Jun 30, 2021 | -10.54 Mn |